38.38
+0.92
+(2.46%)
As of 8:01:07 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 4 | 4 |
Avg. Estimate | 53.01M | 54.21M | 164.29M | 220.63M |
Low Estimate | 52.73M | 53.31M | 164.01M | 213M |
High Estimate | 53.14M | 54.7M | 164.42M | 229.6M |
Year Ago Sales | -- | -- | -- | 164.29M |
Sales Growth (year/est) | -- | -- | -- | 34.29% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ID6.F | -- | -- | -- | -- |
S&P 500 | 9.39% | 11.29% | 14.06% | 13.54% |
Upgrades & Downgrades
Initiated | Wedbush: Outperform | 12/19/2024 |
Maintains | Chardan Capital: Buy | 12/13/2024 |
Maintains | BWS Financial: Buy to Buy | 11/8/2024 |
Initiated | Craig-Hallum: Buy | 9/17/2024 |
Maintains | BWS Financial: Buy to Buy | 8/9/2024 |
Initiated | Maxim Group: Buy | 7/15/2024 |